Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls
Enrolling by invitation · NCT05812339 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls | Chemically-Induced Disorders, Digestive System Diseases, Familial cyclic vomiting syndrome, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cannabinoid hyperemesis syndrome, cannabis dependence, digestive system disorder, gastroparesis, palsy, psychiatric disorder, stomach disorder, substance-related disorder | Enrolling by invitation | Not stated | 2026-04-24 | NCT05812339 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Calgary | 238 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Calgary | Calgary | Canada | 31 |